Purchase Order 75N91022P00749

The Centers for Disease Control and Prevention awarded Abcellera Biologics Inc. a definitive fixed price contract valued at $884,000 to provide a transgenic mouse model capable of generating humanized antibodies against influenza viruses. The original solicitation sought proposals for a mouse engineered with human immunoglobulin gene segments to better recapitulate the human antibody repertoire when testing candidate virus strains and developing antibodies. Under the contract, Abcellera will...

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $121,347 firm fixed price purchase order to Cyagen Biomodels LLC of Santa Clara, California. The contract is for the generation of conditional knock-in and knock-out mouse models to support the agency's research focusing on the development of the mammalian hematopoietic system and study of signal transduction molecules and pathways that regulate T...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a firm-fixed-price delivery order contract to The Jackson Laboratory, a nonprofit biomedical research institution, for the provision of genetically modified humanized mice to support vaccine development research. The $43,440.00 contract has an ultimate completion date of December 31, 2024 and was awarded on September 5, 2024. The Jackson Laboratory, which specializes in mammalian genetics and...

This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ingenious Targeting Laboratory Inc. The contract is valued at $31,245.00 and has a completion date of December 31, 2013. The contract is for the provision of ROSA26 knock-in mice, which are genetically modified mouse models used in biomedical research. The contract was set aside for small businesses, and Ingenious...

This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, was issued to the prime contractor Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The $4,850.10 fixed price award is for a project titled "AMBIS 1736053 PROJECT NO. 1551.6 BREEDING TO GENERATE A...

This firm-fixed-price purchase order was awarded to Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business, to provide services related to creating conditional knockout mice. The $24,850.00 contract was awarded by the Department of Health and Human Services (HHS) and covers activities such as generating a targeting vector and embryonic stem (ES) cells, clone screening, blastocyst injection, mouse breeding, and...

This federal contract award to Ozgene PTY LTD, an Australian company, is for the delivery of genetically modified mice and related services to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific services provided under this $5,970.00 firm fixed price delivery order contract include gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst...

This federal contract award is for Task Order 19 under a broader Delivery Order contract with Ozgene PTY LTD, an Australian company providing genetically modified mice and related services in support of biomedical research. The $67,700.00 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract provides for services such as...

This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $57,600 firm-fixed-price contract was for the generation of conditional gene knockout and knockin mouse models to support biomedical research. Ozgene, as the prime contractor, will provide gene targeting vector design and creation, mouse...

This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene Pty Ltd, an Australian company. The contract, valued at $67,700.00, is for the provision of genetically modified mice and rats to support biomedical research. The contract does not have a set-aside designation. Ozgene, the prime contractor, will provide gene targeting vectors, mouse backcrossing,...